News

New Company Looks to Reimagine Clinical Trials

Written by Yourway | November 1, 2019

Clinical trials management company SignalPath, which just closed an $18 million Series B funding round, is aiming to modernize how clinical trials are conducted, emphasizing workflow, dashboard, and analytic tools to improve the ease, efficiency and profitability of trial execution, particularly for evolving virtual clinical trials models. Yourway is committed to supporting any new models that streamline our customers' clinical trials and get treatments to patients faster.